Britain is reviewing a major contract with American firm Palantir for the National Health Service. The government must decide by early 2027 whether to continue the deal. Concerns about patient data privacy and reliance on a foreign supplier are central to the review. Parliamentarians have urged the government to end the contract, citing risks.

LONDON, June 9 : Britain is conducting a full review of its National Health Service contract with U.S. data analytics firm Palantir, amid growing political pressure for the…

The UK government is reviewing the NHS's £330M Palantir contract and may trigger a 2027 break clause, after MPs called reliance on the US firm a weakness.